2021-08-272021-08-272006Bulut, M. vd. (2006). ''Tau protein as a serum marker of brain damage in mild traumatic brain injury: Preliminary results''. Advances in Therapy, 23(1), 12-22.0741-238X1865-8652https://link.springer.com/article/10.1007/BF02850342https://doi.org/10.1007/BF02850342http://hdl.handle.net/11452/21552The objective of this study was to investigate the diagnostic value of serum tau protein in determining the severity of traumatic brain injury in patients with mild traumatic brain injury (mTBI) and high-risk patients. Adult patients who presented to our emergency department (ED) with mTBI over I year were prospectively enrolled. Patients underwent cranial computed tomography (CT) and were subdivided into high- and low-risk groups, according to the probability of resultant intracranial injury. Serum tau levels of 60 patients and 20 healthy volunteers, who served as a control group, were measured. The mean age of the 60 patients (45 males, 15 females) was 32.5 years (range, 15-66 y). Mean Glasgow Coma Scale (GCS) score was 14 +/- 0.6. CT scans demonstrated intracranial injury in 11 patients (18.3%) and depressed fracture in 4 patients (6.7%). Serum tau levels of patients (188 +/- 210 pg/mL), compared with those of controls (86 48 pg/mL), were relatively higher; however, differences were not statistically significant (P = .445).eninfo:eu-repo/semantics/closedAccessResearch & experimental medicinePharmacology & pharmacySerum tau proteinMild traumatic brain injuryHigh riskCranial CTCsfSerial s-100Neuronal damageComputed-tomographyCerebrospinal-fluidMinor head-injuryArticle0002371189000022-s2.0-33646145064122223116644603Medicine, research & experimentalPharmacology & pharmacyUbiquitin Thiolesterase; Phosphopyruvate Hydratase; Glial Fibrillary Acidic Protein